1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
672C25AA836AA41D300258C150021F43D
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-launching-new-oncology-products-in-competitive-markets-thought-leader-engagement-benchmarking-differentiation-factors?opendocument
18
19opendocument
2018.97.9.169
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Product Launch » Product Launch Excellence

Launching New Oncology Products in Competitive Markets: Thought Leader Engagement and Benchmarking Differentiation Factors

ID: 5850


Features:

13 Info Graphics

22 Data Graphics

410+ Metrics

7 Narratives


Pages/Slides: 43


Published: 2025


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from “Launching New Oncology Products in Competitive Markets: Thought Leader Engagement and Benchmarking Differentiation Factors”

STUDY OVERVIEW

In today’s competitive oncology landscape, launch success hinges on strategic engagement with key stakeholders, including thought leaders, physicians, payers, and patients. Differentiating effectively in this crowded space while educating stakeholders is essential for overcoming market barriers and ensuring long-term impact.

This Best Practices, LLC research explores how organizations can build influential thought leader partnerships to drive successful launches. It also highlights effective approaches for crafting differentiation strategies that resonate with diverse audiences, mitigating risks through robust planning, and avoiding common pitfalls that can derail product launches.

KEY TOPICS

  • Critical success factors observed from oncology launch leaders
  • Current and future risks that can derail oncology launch success
  • The relative value and importance of differentiation factors with different stakeholder audiences (Physicians, Payers, Patients)
  • The effectiveness of engagement and education tactics across stakeholder audiences

KEY METRICS

  • Key success factors influencing oncology product launches
  • Framework for achieving successful market entry in oncology
  • Proven strategies for engaging thought leaders to shape an informed and receptive market
  • Critical resources for thought leader-based market entry activities
  • Methods for identifying and managing oncology thought leaders to maximize impact
  • Leading and secondary differentiation factors influencing physicians during market entry
  • Effective early physician education strategies for influencing market success
  • Strategies for driving a physician’s initial trial with the right patient type for a new oncology product entering a competitive marketplace
  • Avoiding key physician-related pitfalls that could hinder launch success
  • Leading and secondary differentiation factors for payer engagement
  • Best practices for early payer education to ensure pricing and access success
  • Product features that enable premium pricing and meet payer efficacy thresholds
  • Mitigating risks of payer-related challenges that can impact success
  • Leading and secondary factors differentiating products for patients at launch
  • Effective education and engagement strategies to build patient awareness and adoption
  • Identifying and addressing patient-related risks that can undermine product success

SAMPLE KEY FINDINGS

  • Quality of Life and Compliance Differentiate Products for Patients: Patient quality of life emerges as the most effective factor for product differentiation at launch, with the entire benchmark class rating it as extremely effective. Ease of use and compliance (86%) and reduced side effects (86%) follow closely, reflecting patient priorities in choosing treatments. Safety and general efficacy (71% each) further reinforce the importance of aligning messaging with patient-focused outcomes to gain a competitive edge.

METHODOLOGY

Best Practices engaged 8 Oncology-focused launch leaders from 8 companies in this research through a benchmarking survey instrument and interviews. Benchmark partners work in such functions as Marketing, Commercial, and Product Franchises.

Industries Profiled:
Consulting; Biotech; Biopharmaceutical; Pharmaceutical


Companies Profiled:
Ardelis Health; F1 Oncology; Incyte; Lexicon Pharmaceuticals; Regeneron; Sandoz; Shire; Syros Pharmaceuticals

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.